Stock listing

ASX:IXC Invex Therapeutics Ltd. Share Price

Follow Invex Therapeutics Ltd. into a list and get an email when it puts out news.

Share price · ASX:IXC

$0.09 AUD -0.01 (-10.0%)

Delayed at least 15 minutes · 10:56 AM GMT+11, Nov 3, 2026

Past year -13.0% · daily closes, Nov 3, 2025 – Oct 30, 2026, adjusted for splits
Day range so far
$0.09 – $0.09 AUDDelayed at least 15 minutes · 10:56 AM GMT+11, Nov 3, 2026
Volume
2,025 sharesDelayed at least 15 minutes · 10:56 AM GMT+11, Nov 3, 2026
Market cap
$6.76M AUDDelayed at least 15 minutes · 10:56 AM GMT+11, Nov 3, 2026 · price × 75.15M shares outstanding
52-week range
$0.09 – $0.15 AUDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$3,598 AUDMedian day 0 shares · 38 days with no trades · last 3 months, Aug 3, 2026 – Oct 30, 2026
Invex Therapeutics Ltd. logo

Daily closes

Last 3 months, Aug 3, 2026 – Oct 30, 2026 · ASX:IXC · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.100.000.0%$0.10$0.10$0.100
$0.100.000.0%$0.10$0.10$0.100
$0.100.000.0%$0.10$0.10$0.100
$0.10-0.02-16.7%$0.10$0.10$0.1086,747
$0.12+0.015+14.3%$0.11$0.12$0.105475,676
$0.1050.000.0%$0.105$0.105$0.1050
$0.1050.000.0%$0.105$0.105$0.1050
$0.1050.000.0%$0.105$0.105$0.1050
$0.1050.000.0%$0.105$0.105$0.1050
$0.1050.000.0%$0.105$0.105$0.10543,963
$0.1050.000.0%$0.105$0.105$0.10515,866
$0.105-0.01-8.7%$0.11$0.11$0.1098,158
$0.115+0.01+9.5%$0.11$0.115$0.11180,126
$0.105-0.005-4.5%$0.105$0.105$0.10541,238
$0.110.000.0%$0.11$0.11$0.111
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.1155
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.11+0.005+4.8%$0.11$0.11$0.11123,283
$0.1050.000.0%$0.105$0.105$0.1050
$0.1050.000.0%$0.105$0.105$0.1050
$0.105-0.01-8.7%$0.115$0.115$0.10510,053
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1152
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.11555
$0.1150.000.0%$0.115$0.115$0.1150
$0.115+0.01+9.5%$0.115$0.115$0.115100,000
$0.105-0.005-4.5%$0.11$0.11$0.10573,398
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.11-0.02-15.4%$0.11$0.11$0.113,000
$0.130.000.0%$0.13$0.13$0.13753
$0.130.000.0%$0.13$0.13$0.135,958
$0.13+0.01+8.3%$0.13$0.13$0.13103,873
$0.120.000.0%$0.12$0.12$0.120
$0.120.000.0%$0.12$0.12$0.120
$0.12+0.01+9.1%$0.13$0.13$0.115359,487
$0.110.000.0%$0.11$0.11$0.110
$0.11-0.005-4.3%$0.115$0.115$0.11158,817
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.12$0.12$0.11548,485
$0.1150.000.0%$0.115$0.115$0.1156,250
$0.1150.000.0%$0.115$0.115$0.1152,500
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.1150
$0.1150.000.0%$0.115$0.115$0.11520,000
$0.115+0.005+4.5%$0.115$0.115$0.11553,006
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.110
$0.110.000.0%$0.11$0.11$0.1121,204
Ticker
ASX:IXC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Invex to Acquire Rekover Therapeutics

Oct 25, 2026

Closed $0.12 (+14.3%) on Oct 26, 2026

Trading Halt

Oct 21, 2026

Closed $0.105 (0.0%) on Oct 22, 2026

Appendix 4D and Half Year Report

Feb 12, 2026

Closed $0.11 (-12.0%) on Feb 13, 2026

Reinstatement to Quotation

Nov 9, 2025

Closed $0.12 (+4.3%) on Nov 10, 2025

Suspension from Official Quotation

Nov 7, 2025

Closed $0.12 (+4.3%) on Nov 10, 2025

Pause in Trading

Nov 7, 2025

Closed $0.12 (+4.3%) on Nov 10, 2025

All Invex Therapeutics Ltd. news

Decks

Invex Therapeutics Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 73 in all · newest Oct 30, 2026 · oldest 2019
Decks
16 decks · latest Nov 22, 2022

Log in to ask 6ix AI your own questions about Invex Therapeutics Ltd.